Business Wire

Gurobi Releases OptiMods, An Open-Source Python Repository of Optimization Use Cases

Share

Gurobi Optimization, LLC, the leader in decision intelligence technology, today announced the release of OptiMods, an open-source project that provides Python users with high-level access to optimization capabilities. Developed by the Gurobi Tech teams, the project aims to put optimization in the hands of more people—especially those without prior knowledge of optimization and mathematical modeling.

“Many people have real-life business problems that can be solved with mathematical optimization, and they don’t even realize it. OptiMods helps bridge that gap,” explained Dr. Robert Luce, Principal Developer at Gurobi and the lead developer behind the project.

At launch, the OptiMods gallery includes the following modules:

  • Maximum Bipartite Matching: For grouping and assignments, such as matching workers or resources to specific tasks.
  • Least Absolute Deviation Regression: For outlier detection and financial risk management, as well as applications across economics, social sciences, and environmental studies.
  • Minimum-Cost Flow: For problems where the goal is to route a certain amount of flow in the cheapest way.
  • Maximum Weighted Independent Set: For a range of applications in various fields, including computer vision, pattern recognition, molecular structure matching, social network analysis, and genome data mapping.
  • Mean-Variance Portfolio: For strategic allocation of wealth across various assets, including stocks, bonds, commodities, and other investment instruments.
  • Quadratic Unconstrained Binary Optimization (QUBO): For NP-hard discrete optimization problems like max-cut, graph coloring, partitioning, and maximum independent set.
  • Workforce Scheduling: For problems that involve balancing many competing concerns, such as: worker availability, cost, and preferences; shift coverage requirements; conditions on consecutive shifts or rest breaks; and so on.

“Of course, there are millions of different problems that can be solved with optimization,” he added. “OptiMods only covers seven of them. But it’s a start.”

With OptiMods, people can solve problems that would be very difficult or impossible to solve without any optimization methods. Gurobi hopes that, through OptiMods, more people will discover that optimization is a useful tool that can be used more prominently in the workplace.

“OptiMods represents a big step toward putting the power of optimization into the hands of more people,” explained Gurobi CEO, Duke Perrucci. “When people and businesses make optimal decisions, they can do more with less—and, over time, that can make our world a better place. That’s what we’re aiming for as an organization.”

OptiMods includes example datasets for each module, all of which can be run using the free, limited-size Gurobi license that is automatically included in the Gurobi Python interface, gurobipy. Larger datasets require a full license. Academics have access to full-featured Gurobi Academic Licenses for free; commercial users can request a Gurobi Evaluation License.

The Gurobi team would like to grow the OptiMods collection over time. As such, it invites people familiar with optimization to contribute new Mods covering their favorite problems.

Gurobi will host a series of webinars on June 27, July 5, and July 6 to introduce the OptiMods project, demonstrate several of the current set of Mods, and outline how users can contribute. Register for the “Gurobi OptiMods: Simple APIs for Common Optimization Tasks” at https://ow.ly/a98C50OUcuP.

About Gurobi Optimization

With Gurobi’s decision intelligence technology, you can make optimal business decisions in seconds. From workforce scheduling, portfolio management, and marketing optimization, to supply chain design, and everything in between, Gurobi identifies your optimal solution, out of trillions of possibilities.

As the leader in decision intelligence, Gurobi delivers easy-to-integrate, full-featured software and best-in-class support, with an industry-leading 98% customer satisfaction rating.

Founded in 2008, Gurobi has operations across the Americas, Europe, and Asia. Over 2,500 global customers across 40+ industries run on Gurobi, including SAP, Air France, and the National Football League, as well as over half of the Fortune 10 and 70% of top global tech companies. For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Nell-Marie Colman
(540) 952 9719
Gurobi Optimization
colman@gurobi.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release

I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA ® Commercialization in Central and Eastern Europe7.1.2026 09:30:00 EET | Press release

Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnosed FLT3-ITD positive AML in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, and as maintenance monotherap

Thales Powers CES*-Winning Post-Quantum Chip From Samsung Electronics7.1.2026 09:15:00 EET | Press release

Quantum computers, with their unprecedented processing power, will ultimately challenge today’s encryption standards. This is why Thales welcomes the CES 2026 recognition awarded to the new post-quantum–ready security chip from Samsung Electronics' System LSI Business, which embeds Thales’ secure operating system and quantum-resistant cryptographic libraries. This breakthrough represents a major step forward in protecting connected devices against both current cyberattacks and tomorrow’s quantum-era threats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106145232/en/ Thales’ hardened OS enables Samsung's award-winning security chip to deliver hardware-based, quantum-resistant protection from the moment devices power on. Ultimately, it ensures that encrypted data and device credentials remain secure against both classical and quantum attacks, preserving confidentiality, integrity and long-term trust, even in a post-quantu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye